Table 3.

REV7 predicts outcomes In various cancers.

Cancer Type	Prognostic Indicator	Reference
Triple negative breast	High REV7 expression is associated with shorter overall survival	(157)
Diffuse large B-cell lymphoma	High REV7 expression is associated with shorter progression-free survival and overall survival in patients treated with rituximab	(158)
Gastric	High REV7 expression is associated with shorter overall survival	(157)
Lung	High REV7 expression is associated with shorter overall survival	(157)
Melanoma	High REV7 expression is associated with increased tumor thickness	(159)
Ovarian	High REV7 expression is associated with shorter overall survival	(182)
Ovarian clear cell carcinoma	High REV7 expression is associated with shorter progression-free survival in advanced disease	(181)
Pancreatic ductal adenocarcinoma	High REV7 expression is associated with shorter overall survival in unresectable PDAC treated with platinum-based chemotherapy	(160)
Testicular germ cell	High REV7 expression is associated with chemotherapeutic resistance and shorter overall survival	(161, 162)